Temasek's entry allows EILSF exit from HealthCare Global Enterprises. Temasek, the sovereign wealth fund of Singapore has invested Rs140 crore for shareholdings in HealthCare Global Enterprises or HCG.
Healthcare Health/Fitness
Affymax Continues Tumble
Affymax's drug recall Ormontys caused decline of the company. Pharmaceutical firm Affymax continued its decline after it fired nearly three fourths of its labor complement and is now in the process of opting for a sale or declaration of bankruptcy.
Complete Genomics Acquired by BGI-Shenzhen
BGI-Shenzhen acquires Complete Genomics after regulatory approvals from China and the US were obtained.
Walgreen Enters Distribution Deal with AmerisourceBergen
AmerisourceBergen does a deal with Walgreen and Alliance Boots. AmerisourceBergen, the pharmaceuticals distribution giant, has entered into a ten year distribution agreement with Walgreen Co and its associate Alliance Boots GmbH.
Cynosure Acquires Palomar
Cynosure purchases Palomar's light based technology for US$294 million. Cynosure Inc has purchased Palomar Medical Technologies for US$294 million.
Latest News
Chairman of Simcere to buyout shares. A consortium led by its Chairman Jinsheng Ren has offered to buyout Simcere Pharmaceutical Group. The China based pharmaceutical firm was priced at US$9.
Elan proceeds with its US$1 billion buyback share program. Elan is expected to undertake the planned US$1 billion share buyback by next week. The Irish pharmaceutical firm's move may undermine the takeover offer by US fund firm Royalty Pharma.
Royalty Pharma offers US$6.6 billion for Elan purchase. In a standoff, Royalty Pharma has reiterated its offer to purchase Elan, the Irish pharmaceutical firm on the same terms despite being previously rejected.
Investor AB pays for 45 kronor per share of six million shares of Active Biotech. Active Biotech AB's share values rose to its highest levels after an 8% stake in the company was purchased by AB.
Royalty Pharma has expressed confidence in its bid to buy out Irish drugmaker Elan, saying that its takeover offer is an attractive alternative.
Consortium of equity firms deliberating on whether to pursue purchase of Life Tech. A joint offer is being mulled for the purchase of Life Technologies Corp.
Allscripts buys partner dbMotion. In a clear move to expand markets, North American medical information firm Allscripts Healthcare Solutions is purchasing dbMotion, the Israeli healthcare provider.
Shareholders of Roche have agreed on a company pay plan after Swiss citizens voted on the imposition of a ban on big pays for managers in the country.
American healthcare firm Allscripts has bought Israel's software provider dbMotion in a deal amounting $235 million.
